Physician profile
Steven Abram
NPI 1285604454
$12,920.00
in general payments reported to CMS, 2019-2025
14 companies · $1,043 in 2025
The $1,043 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,366 · 2020: $1,253 · 2021: $1,944 · 2022: $2,257 · 2023: $1,317 · 2024: $741 · 2025: $1,043.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,600 · Food and Beverage: $1,501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,600.00 |
| Food and Beverage | $1,500.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Monteris Medical Corporation | $10,716.63 | 2019-2025 | Neuroblate |
| Brainlab, INC. | $487.67 | 2019-2023 | Image Guided Surgical Device |
| Abbott Laboratories | $473.43 | 2019-2024 | Proclaim |
| Augmedics INC. | $310.41 | 2024 | Xvision |
| Medtronic, INC. | $227.39 | 2023-2024 | Unid_pass, Prestige Lp Cervical Disc System, Mazor X System |
| Merck Sharp & Dohme LLC | $125.02 | 2025 | Keytruda |
| Spine Wave, INC. | $119.90 | 2019 | |
| Novocure INC. | $118.15 | 2025 | Optune Gio |
| Synaptive Medical INC. | $106.69 | 2021 | |
| Depuy Synthes Sales INC. | $104.42 | 2019 | |
| Medtronic USA, INC. | $52.50 | 2020 | |
| Stryker Corporation | $44.87 | 2022 | |
| Zimmer Biomet Holdings, INC. | $19.95 | 2019 | |
| Integra Lifesciences Corporation | $12.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Abram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.